Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions
Multiple SclerosisAnxietyDepressionPatient Satisfaction
Interventions
OTHER

Intensive Use of Patient Reported Outcome Measures and Open PROM Availability to Treating Neurologist

"Baseline, 6 months, and 12 months administration of HADS, EQ5D, MFIS, PDDS, PHQ-9 questionnaires in addition to Open ended text response to (limit 280 characters) What are the top 3 things you would like your MS Neurologist to know about you right now?~Additionally, the treating neurologist will be prompted to view the text response to the 3-item prompt in addition to the PROM questionnaire scores for participants in the interventional group."

OTHER

Conservative Use of Patient Reported Outcome Measures and Blinded PROM Availability to Treating Neurologist

"Baseline and 12 months administration of HADS, EQ5D, MFIS, PDDS, PHQ-9 questionnaires in addition to Open ended text response to (limit 280 characters) What are the top 3 things you would like your MS Neurologist to know about you right now?~Additionally, the treating neurologist will only be prompted to view the text response to the 3-item prompt, and will not be able to access the PROM questionnaire scores for participants in the control group."

Trial Locations (1)

T6G 2R3

University of Alberta, Edmonton

All Listed Sponsors
collaborator

University Hospital Foundation

OTHER

lead

University of Alberta

OTHER

NCT04979546 - Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis | Biotech Hunter | Biotech Hunter